Real Estate Archives - Page 8 of 23

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

May 7, 2025

THIS WEEK'S STORIES

Akamis Bio Expands Executive Team to Support Advancing Immunotherapy Pipeline

May 6, 2025

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

May 7, 2025

Massachusetts Nurses Sound Alarm on Patient Safety, Staffing, and Violence in 2025 State of Nursing Survey

May 5, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Real Estate

Pharmavite Opens $250 Million Vitamin Manufacturing and R&D Facility in New Albany, Ohio

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

J. Craig Venter Institute to Relocate West Coast Operations to San Diego’s Waterfront Research and Development District

Diversified Healthcare Trust Secures $109 Million Mortgage Financing for Senior Living Communities

Healthpeak and Hines Partner on Cambridge Point Mixed-Use Development in Cambridge, Massachusetts

Most Read

GSK and Lifetime Team Up to Raise Awareness of Meningitis Through New Original Movie

What’s a fair price for a drug that’s never developed?

QuantHealth Launches First Clinical AI Foundation Model for Life Sciences Industry

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

EDITOR PICKS

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

THIS WEEK'S STORIES

Akamis Bio Expands Executive Team to Support Advancing Immunotherapy Pipeline

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

Massachusetts Nurses Sound Alarm on Patient Safety, Staffing, and Violence in 2025 State of Nursing Survey

POPULAR CATEGORY

ABOUT US

FOLLOW US